WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

What’s New in the 2024 CLSI Standards for Antimicrobial Susceptibility Testing?

CLSI 2024 M100 Update Webinar

What’s New in the 2024 CLSI Standards for Antimicrobial Susceptibility Testing?

Date: April 17, 2024 | 1:00-2:30 PM ET

Janet Hindler, MCLS, MT(ASCP), F(AAM)
Clinical Microbiologist, Los Angeles County Department of Public Health

April Bobenchik, PhD, D(ABMM)
Medical Director Microbiology and Associate Professor, Penn State Health and College of Medicine
Romney Humphries, PhD D(ABMM)
Professor, Department of Pathology, Microbiology and Immunology
Vanderbilt University Medical Center

Join CLSI for a webinar on the latest in Antimicrobial Susceptibility Testing (AST) with the release of the 34th edition of the CLSI M100 document. Receive the latest guidance for implementing new breakpoints and standards into your laboratory practices. Some of the major changes that will be discussed during the webinar include a significant reorganization of dosage recommendations, addition of sulbactam-durlobactam to breakpoints, a new Table 2A-2 for Salmonella and Shigella, and many more. A few substantive changes to the upcoming CLSI M02 and M07 will also be discussed.

Watch the webinar live or view on-demand anytime. The on-demand recording will be available on April 19, 2024.

Member price:

List Price:
Log in/sign up to see price and add to cart


Date of Webinar: April 17, 2024

CLSI 2024 M100 Update Webinar Additional Details

Learning Objectives:

1. Identify the major changes found in the updated 34th edition of the CLSI M100 document.
2. Design a strategy for implementing the new standard into laboratory practices.
3. Develop a communication strategy for informing clinical staff of significant AST and reporting changes.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.